Disease management

Also, Mediwhale raised $12 million for its United States expansion.

The CGM biosensor offers high antinoise ability and tunable sensitivity and resolution.

The partnership aims to increase member engagement and improve health outcomes.

The tech aims to deliver AI-driven drug response prediction to human oncology.  

Also, Japan has approved iRhythm's AI-based continuous ECG monitoring system.

Cardio Intelligence is now testing its latest AI for detecting paroxysmal atrial fibrillation. 

Crohn’s Colitis Cure is coming up with a unique cloud-connected IBD consumer app.

DarioHealth, a digital chronic condition management platform, announced the integration of Twill's condition-specific communities and peer groups with customized navigation expertise into its cardiometabolic platform.

The partners will work to bring AI-powered motion-capture technology to the physical therapy market in order to reduce administrative workloads.

The collaboration will integrate NeuroFlow's workflow tools into the medical center's ambulatory care settings.